The role of ADAM17 in colon cancer is thought to be linked to ADAM17-mediated shedding of EGF-R activating ligands, as well as IL-6 trans-signaling, which is also promoted by ADAM17 via the shedding of IL-6R [43]. This evidence concerns the gene IL6R and malignant colon neoplasm.